Author
Listed:
- Jennifer Ducie
(Memorial Sloan Kettering Cancer Center
Mercy Medical Center)
- Fanny Dao
(Memorial Sloan Kettering Cancer Center
New York University Langone Health)
- Michael Considine
(Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)
- Narciso Olvera
(Memorial Sloan Kettering Cancer Center
New York University Langone Health)
- Patricia A. Shaw
(University Health Network)
- Robert J. Kurman
(Johns Hopkins Medical Institutions)
- Ie-Ming Shih
(Johns Hopkins Medical Institutions)
- Robert A. Soslow
(Memorial Sloan Kettering Cancer Center)
- Leslie Cope
(Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins)
- Douglas A. Levine
(Memorial Sloan Kettering Cancer Center
New York University Langone Health)
Abstract
Many high-grade serous carcinomas (HGSCs) of the pelvis are thought to originate in the distal portion of the fallopian tube. Serous tubal intra-epithelial carcinoma (STIC) lesions are the putative precursor to HGSC and identifiable in ~ 50% of advanced stage cases. To better understand the molecular etiology of HGSCs, we report a multi-center integrated genomic analysis of advanced stage tumors with and without STIC lesions and normal tissues. The most significant focal DNA SCNAs were shared between cases with and without STIC lesions. The RNA sequence and the miRNA data did not identify any clear separation between cases with and without STIC lesions. HGSCs had molecular profiles more similar to normal fallopian tube epithelium than ovarian surface epithelium or peritoneum. The data suggest that the molecular features of HGSCs with and without associated STIC lesions are mostly shared, indicating a common biologic origin, likely to be the distal fallopian tube among all cases.
Suggested Citation
Jennifer Ducie & Fanny Dao & Michael Considine & Narciso Olvera & Patricia A. Shaw & Robert J. Kurman & Ie-Ming Shih & Robert A. Soslow & Leslie Cope & Douglas A. Levine, 2017.
"Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma,"
Nature Communications, Nature, vol. 8(1), pages 1-9, December.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-01217-9
DOI: 10.1038/s41467-017-01217-9
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-01217-9. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.